Best Practices for Cell and Gene Therapy Trials

This guide outlines best practices for managing clinical operations in cell and gene therapy (CGT) trials, emphasizing the complexities involved in ensuring patient safety and data quality. It details the importance of selecting appropriate trial designs and endpoints, highlighting the need for collaboration among project managers, clinical data managers, and biostatisticians. The document presents strategies for building effective electronic case report forms (eCRFs) that facilitate accurate data collection, particularly in studies involving graft-versus-host disease (GvHD). It also discusses the significance of centralized data monitoring systems that leverage machine learning to detect anomalies in real-time, thereby enhancing data integrity and trial efficiency. The guide concludes with recommendations for prioritizing logistics to ensure seamless coordination among stakeholders, which is critical for the successful execution of CGT trials. Overall, the document serves as a comprehensive resource for organizations involved in CGT research, sharing lessons learned from extensive experience in the field.